In addition, genetic mutations in epigenetic factors such as the SWI/SNF complex, frequently observed in various cancer types, cause H3K27me3 accumulation by EZH1 and EZH2, and dual inhibitors might be effective in these cases as well [19, 40]. The gene discussed is EZH2; the disease is cancer.